Late Trump-Era Health Rules Now in Effect Are Under Review (1)

Feb. 9, 2021, 6:43 PM UTCUpdated: Feb. 10, 2021, 6:47 PM UTC

Several health regulations that went into effect late in the Trump administration are subject to review—and could change—under the leadership of President Joe Biden.

They include controversial actions like an international drug pricing rule, which is already halted by litigation, as well as straightforward and time-sensitive rules about how doctors get paid under Medicare. The Biden administration’s review of the rules doesn’t mean they’ll be reversed, but it does mean government officials will look at each one and assess whether it meets the public interest.

The review covers rules published in the last 60 days of the Trump administration, ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.